Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0176993 COUPLED DIENE ELASTOMER HAVING A SILANOL FUNCTION IN THE MIDDLE OF THE CHAIN AND HAVING AN AMINE FUNCTION AT...
The invention relates to a modified diene elastomer comprising predominantly the entity functionalized in the middle of the chain by a silanol group, the...
2016/0176992 MODIFIED DIENE ELASTOMER COMPRISING A DIENE ELASTOMER COUPLED BY AN AMINOALKOXYSILANE COMPOUND AND HAVING AN...
The invention relates to a modified diene elastomer comprising predominantly the entity functionalized in the middle of the chain by an alkoxysilane group,...
2016/0176991 CONTINUOUS SYNTHESIS METHOD FOR A MODIFIED DIENE ELASTOMER, FACILITY FOR IMPLENTING SAME
A continuous method for synthesizing a diene includes modifying the diene elastomer in a functionalizing device by: a kinetic model according to which the...
2016/0176990 Mutant Bacterial Strains of the Genus Sphingomonas Deficient in Production of Polyhydroxybutyrate and a ...
The invention relates to mutant strains of the genus Sphingomonas which have a mutation in at least one gene encoding a protein involved in polyhydroxybutyrate...
2016/0176989 METHOD OF MODIFYING NANOFIBRILLAR CELLULOSE COMPOSITION
The invention relates to a method for modifying nanofibrillar cellulose composition, comprising--preparing fibrous dispersion of ionically charged...
2016/0176988 DNA-Nanoparticle Conjugates
The bio-programmable crystallization of multi-component functional nanoparticle systems is described, as well as methods for such bio-programmable...
2016/0176987 METHOD OF TREATING A PATHOLOGICAL SYNDROME AND A PHARMACEUTICAL AGENT
A method of treating a pathological syndrome includes administration of an activated form of ultra-low doses of antibodies to an antigen, wherein said...
2016/0176986 HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS
The present application discloses high-concentration monoclonal antibody formulations suitable for subcutaneous administration, e.g. via a pre-filled syringe....
2016/0176985 HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE
The present invention comprises a humanized monoclonal antibody that binds to the chemokine receptor CCR4. This antibody is derived from Mab 1567 and...
2016/0176984 CYTOTOXIC IMMUNOGLOBULIN
The invention relates to a cytotoxic;modular antibody with a molecular weight of up to 6OkD, specifically binding to a cell surface target with a binding...
2016/0176983 INTERCALATED SINGLE-CHAIN VARIABLE FRAGMENTS
Single chain antibody polypeptides with engineered peptide bond crossovers in the light chain and/or heavy chain variable domains, compositions comprising the...
2016/0176982 Fc VARIANTS WITH ALTERED BINDING TO FcRn
The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for...
2016/0176981 ANTI-GD2 ANTIBODIES
In this application are described chimeric, humanized, affinity matured, stability enhanced, and bispecific Anti-GD2 antibodies and fragments thereof. Also...
2016/0176980 T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
The present invention concerns compositions and methods of use of T-cell redirecting complexes, with at least one binding site for a T-cell antigen and at...
2016/0176979 METHODS AND COMPOSITIONS RELATED TO SINGLE CHAIN ANTIBODY FRAGMENTS THAT BIND TO TUMOR-ASSOCIATED GLYCOPROTEIN...
Disclosed herein are methods and compositions related to single chain antibody fragments which specifically bind sialyl-Tn epitope of tumor-associated...
2016/0176978 Methods of Manipulating Phagocytosis Mediated by CD47
Methods are provided to manipulate phagocytosis of cancer cells, including e.g. leukemias, solid tumors including carcinomas, etc.
2016/0176977 NOVEL ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER
A novel gene 0161P2F10B (also designated 161P2F10B) and its encoded protein, and variants thereof, are described wherein 161P2F10B exhibits tissue specific...
2016/0176976 Methods of Manipulating Phagocytosis Mediated by CD47
Methods are provided to manipulate phagocytosis of cancer cells, including e.g. leukemias, solid tumors including carcinomas, etc.
2016/0176975 GENERATION OF A CANCER-SPECIFIC IMMUNE RESPONSE TOWARD MUC1 AND CANCER SPECIFIC MUC1 ANTIBODIES
The present invention provides a method for inducing a cancer specific immune response against MUC1 using an immunogenic glycopeptide. Other aspects of the...
2016/0176974 METHOD FOR TREATING JOINT DAMAGE
Methods of treating joint damage in a subject eligible for treatment are provided involving administering an antagonist that binds to a B-cell surface marker,...
2016/0176973 BINDING MOLECULES FOR BCMA AND CD3
The present invention relates to a binding molecule comprising a first and a second binding domain, wherein the first binding domain is capable of binding to...
2016/0176972 Prion Protein as a Receptor for Amyloid-Beta Oligomers
The invention provides methods of inhibiting suppression of long term potentiation, improving acute memory retention and spatial memory performance and...
2016/0176971 METHODS AND COMPOSITIONS RELATING TO ANTI-IL-21 RECEPTOR ANTIBODIES
The present invention provides compositions and methods relating to antigen binding proteins against IL-21 receptor.
2016/0176970 PEPTIDE OR PEPTIDE COMPLEX BINDING TO ALPHA2 INTEGRIN AND METHODS AND USES INVOLVING THE SAME
The present invention relates to a peptide or peptide complex binding to .alpha.2 integrin, to one or more nucleic acid(s) coding for the peptide or peptide...
2016/0176969 HETERODIMERIC ANTIBODIES INCLUDING BINDING TO CD8
The invention provides bispecific antibodies that co-engage CD8 (preferably bivalently) and a target tumor antigen.
2016/0176968 T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
The present invention concerns compositions and methods of use of T-cell redirecting complexes, with at least one binding site for a T-cell antigen and at...
2016/0176967 METHODS AND MATERIALS FOR TREATING CANCER
This document provides methods and materials involved in treating cancer. For example, methods and materials for identifying a mammal as having an elevated...
2016/0176966 ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME
A hybridoma cell which has been deposited under ATCC Accession Number PTA-9974 is disclosed. Also provided are Antibodies and methods of using same.
2016/0176965 CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT...
Cytotoxic anti-LAG-3 monoclonal antibodies or fragments thereof causing depletion of LAG-3.sup.+ activated T cells are described, as are related ...
2016/0176964 SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS
Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
2016/0176963 ANTIBODIES TO TIGIT
The present invention provides antibodies, or antigen binding fragments thereof, that bind to human TIGIT (T cell immunoreceptor with Ig and ITIM domains), as...
2016/0176962 Combination Therapy For Treatment Of Disease
The present invention provides methods comprising combination therapy for modulating immune responses, for inhibiting tumor growth, and/or for treating cancer....
2016/0176961 THROMBOPOIETIN RECEPTOR LIGANDS FOR NEUROPROTECTION
Methods for the treatment of an ischemic event (e.g., stroke) that creates or embodies a risk of neurological damage in CNS sites by administration of a...
2016/0176960 ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR PREVENTION OR...
Subject matter of the present invention is an anti-adrenomedullin (ADM) antibody or an anti-adrenomedullin antibody fragment or an anti-ADM non-Ig scaffold for...
2016/0176959 STABLE AND SOLUBLE ANTIBODIES
The invention provides antibodies that are modified to reduce aggregration propensity, and methods of producing such antibodies. The present invention also...
2016/0176958 TNF-ALPHA BINDING PROTEINS
Isolated binding proteins, e.g., antibodies or antigen binding portions thereof, which bind to tumor necrosis factor-alpha (TNF-.alpha.), e.g., human...
2016/0176957 Use of TNFalpha Inhibitor
The invention describes methods of treating erosive polyarthritis comprising administering a TNF.alpha. antibody, or antigen-binding portion thereof. The...
2016/0176956 COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING BMP6
The present invention relates to antibodies and antigen-binding fragments thereof to human BMP6 and compositions and methods of use thereof.
2016/0176955 Anti-Malarial Compositions
This disclosure provides antibodies that are useful for preventing and/or treating malaria. The epitope to which the antibodies bind is in close proximity to...
2016/0176954 Anti-C5 Antibodies and Methods of Use
An objective of the invention is to provide anti-C5 antibodies and methods of using the same. The invention provides anti-C5 antibodies and methods of using...
2016/0176953 Human Antibodies to Influenza Hemagglutinin
The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, ...
2016/0176952 PHAGE DISPLAYING SYSTEM EXPRESSING SINGLE CHAIN ANTIBODY
Disclosed are nucleic acid libraries for identifying a signal peptide that facilitates production of disulfide-stabilized single chain antibody, and for...
2016/0176951 SYNTHETIC LIBRARY OF SPECIFIC BINDING MOLECULES
The present invention provides methods for the production of a library of antigen specific antigen binding molecules having a peptide domain structure...
2016/0176950 Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
The invention provides a polypeptide containing at least one IgG Fc region, wherein said at least one IgG Fc region is glycosylated with at least one galactose...
2016/0176949 SILK-ELASTIN LIKE PROTEIN POLYMERS FOR EMBOLIZATION AND CHEMOEMBOLIZATION TO TREAT CANCER
A chemoembolic agent is disclosed that includes an injectable, recombinantly synthesized silk-elastin like protein copolymer and one or more chemotherapeutic...
2016/0176948 THROMBOSPONDIN-1 POLYPEPTIDES AND METHODS OF USING SAME
The invention features thrombospondin-1 (TSP-1) polypeptides (e.g., 3TSR-Fc fusion proteins), nucleic acid molecules encoding the TSP-1 polypeptides, and...
2016/0176947 CONTAMINANT REMOVAL METHOD
A method for purifying Apo A-l is provided including the steps of providing a solution comprising Apo A-l and guanidine hydrochloride and filtering the...
2016/0176946 PROCESS FOR PREPARING APOLIPOPROTEIN A-I (APO A-I)
The present invention relates to processes of obtaining Apo A-1 from an Apo A-1 containing protein fraction (A), comprising suspending--the Apo A-1 containing...
2016/0176945 FGFR-FC Fusion Proteins and the Use Thereof
The present invention belongs to the field of biotechnology and relates to the treatment of diseases, especially the treatment of FGF overexpression-related...
2016/0176944 OLIGOMERIC RECEPTOR LIGAND PAIR MEMBER COMPLEXES
This invention concerns an oligomeric receptor-ligand pair member in general and an oligomeric MHC-peptide complex in particular and a method of labeling,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.